Clinical Trial Name - Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Chronic Plaque-Type P
| Original Study ID : Ext. 1 to ASM981C201 |
| NCT ID : NCT00098189 |
| Brief Title : Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Chronic Plaque-Type Psoriasis |
| Official Title : A Follow-Up Study of Patients Previously Treated in a Core Study With Pimecrolimus Tablets for Chronic Plaque-Type Psoriasis |
| Brief Summary :
This extension study is being conducted to collect post-treatment safety information on
patients who previously participated in the core clinical trial.
|
| Source : Novartis |
| Overall Status : Completed |
| Start Date : July 2004 |
| Official Title : Phase 2 |
| Phase : Observational |
| Study Design : Natural History, Longitudinal, Defined Population, Retrospective Study |
| Verification Date : August 2006 |
| First Received Date : December 3, 2004 |
| Trial Eligibility |
Criteria :
Inclusion Criteria:
- Consenting patients who participated in the core clinical trial
|
| Gender : Both |
| Minimum Age : 18 Years |
| Maximum Age : N/A |
| Healthy Volunteers : No |
